(Q41727174)

8 October 2017

title

A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia (English)

1 reference

8 October 2017

author

Frederick R. Appelbaum

9

object named as

Appelbaum FR

1 reference

8 October 2017

Rosen PJ

1

1 reference

8 October 2017

Rankin C

2

1 reference

8 October 2017

Head DR

3

1 reference

8 October 2017

Boldt DH

4

1 reference

8 October 2017

Luthardt FW

5

1 reference

8 October 2017

Norwood T

6

1 reference

8 October 2017

Pugh RP

7

1 reference

8 October 2017

Karanes C

8

1 reference

8 October 2017

publication date

1 March 2000

1 reference

8 October 2017

1 reference

8 October 2017

volume

24

1 reference

8 October 2017

issue

3

1 reference

8 October 2017

page(s)

183-187

1 reference

A new regimen of amsacrine with high-dose cytarabine is safe and effective therapy for acute leukemia

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900148-4

7 January 2021

Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900148-4

7 January 2021

Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900148-4

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900148-4

7 January 2021

Mitoxantrone and intermediate‐dose cytosine arabinoside for poor‐risk acute leukemias: Response to treatment and factors influencing outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900148-4

7 January 2021

High-dose cytosine arabinoside and mitoxantrone in previously-treated acute leukemia patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900148-4

7 January 2021

Treatment of adult patients with acute lymphocytic leukemia in relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900148-4

7 January 2021

Cytarabine with high-dose mitoxantrone induces rapid complete remissions in adult acute lymphoblastic leukemia without the use of vincristine or prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900148-4

7 January 2021

10.1016/S0145-2126(99)00148-4

Identifiers

DOI

1 reference

8 October 2017

1 reference